Hepamac Tablet contains a combination of L-Ornithine L-Aspartate (250 mg) and Silymarin (140 mg), formulated to support liver health and function. L-Ornithine L-Aspartate is an amino acid compound that plays a crucial role in the detoxification process by facilitating the removal of ammonia from the bloodstream, thereby aiding in the management of hepatic encephalopathy and other liver-related metabolic disturbances. Silymarin, a flavonoid complex extracted from the milk thistle plant, exhibits potent antioxidant, anti-inflammatory, and hepatoprotective properties. It helps stabilize liver cell membranes, promotes regeneration of damaged hepatocytes, and protects against toxin-induced liver injury. The combined action of these active ingredients makes Hepamac Tablet effective in improving liver function in patients with chronic liver diseases such as cirrhosis, hepatitis, and fatty liver disease. Additionally, it may alleviate symptoms related to liver dysfunction, including fatigue, malaise, and digestive disturbances. Hepamac is generally well tolerated when used as directed; however, it should be administered under medical supervision, particularly in patients with severe hepatic impairment or those on concurrent medications. Regular monitoring of liver function tests is recommended to assess therapeutic response and ensure safety.